Palantir's exceptional earnings, fueled by its AI platform, highlight a massive market expansion for data analytics. This trend suggests a significant growth opportunity for other companies operating within the broader AI and data infrastructure ecosystem.
11์ 4 ๊ฒ์
Palantir's exceptional earnings and raised guidance validate the massive commercial and governmental demand for AI-driven data analytics, signalling a robust expansion across the entire ecosystem.
As organisations race to transform data into actionable intelligence, companies providing the essential infrastructure and platforms are positioned to capture significant value from this technological shift.
This collection spans the complete AI data value chain, from cloud providers to specialised software developers, offering diversified exposure to one of technology's fastest-growing sectors.
Palantir's exceptional earnings and raised revenue guidance signal a major inflection point for the AI data ecosystem. This validates accelerating demand for AI-driven analytics across government and commercial sectors, creating a favourable environment for companies throughout the data value chain.
This collection spans the entire AI data infrastructure, from cloud providers to specialised AI software developers. These companies enable organisations to transform vast datasets into actionable intelligence, positioning them to benefit from the expanding market for data analytics solutions.
Each company was handpicked by professional analysts for its role in the AI data ecosystem. From Palantir's central platform to supporting infrastructure providers, these stocks represent various ways to gain exposure to the growing demand for sophisticated data analytics capabilities.
Summarised market capitalisation and investor key points for the basket.
PLTR: $491.29B
SNOW: $93.90B
INFA: $7.57B
์ด ๋ฐ์ค์ผ์ ์ ์ฒด ์คํ ๋ฆฌ๋ฅผ ํ์ธํ์ธ์. ๋ฆฌ์คํฌ์ ์ ์ฌ๋ ฅ์ ๋ค๋ฃฌ ์์ธ ๊ธฐ์ฌ๋ฅผ ์ฝ์ด๋ณด์ธ์.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+7
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
์ด ์์ฐ๋ค์ ํฌ์ํ๋ค๋ฉด:
12๊ฐ์ ํ ์์ ๊ฐ์น:
+96.07%
์ ๋๋ฆฌ์คํธ๋ค์ ์ด ๊ทธ๋ฃน์ ์์ฐ์ด ํฅํ 1๋ ๊ฐ ํ๊ท 96.07% ์ฑ์ฅํ ๊ฒ์ผ๋ก ์์ํฉ๋๋ค.
์ด ๊ทธ๋ฃน์ ์์ฐ 17๊ฐ ์ค 13๊ฐ๊ฐ ์ ๋ฌธ ์ ๋๋ฆฌ์คํธ๋ก๋ถํฐ ๋งค์ ์๊ฒฌ์ ๋ฐ์์ต๋๋ค.
